1. The patient has developed hypersensitivity to abacavir.
2. Abacavir is used to treat HIV infection.
3. The doctor prescribed a daily dose of abacavir for the patient.
4. The effectiveness of abacavir may be diminished by other medications.
5. Abacavir may cause liver problems in some patients.
6. The patient experienced a rash after taking abacavir.
7. Abacavir must be administered with caution in patients with cardiovascular disease.
8. The recommended dosing for abacavir is based on body weight.
9. Abacavir is classified as a nucleoside reverse transcriptase inhibitor.
10. The patient's viral load decreased significantly after starting treatment with abacavir.
11. Abacavir should not be used alone to treat HIV infection.
12. The doctor ordered a blood test to monitor the patient's abacavir levels.
13. The patient experienced allergic reactions to other antiviral medications and was prescribed abacavir.
14. Abacavir is taken orally, typically twice daily.
15. Abacavir is not effective against other types of viral infections.
16. The patient was instructed to notify their healthcare provider immediately if they experienced any symptoms while taking abacavir.
17. Abacavir may interact with certain antibiotics and antifungal medications.
18. The patient's abacavir dosage was adjusted due to renal impairment.
19. Abacavir should not be used during pregnancy or while breastfeeding.
20. The patient's abacavir treatment was interrupted due to low white blood cell count.
21. Abacavir may cause lactic acidosis in rare cases.
22. The doctor consulted with a specialist before prescribing abacavir to the patient.
23. Abacavir is available in both tablet and oral solution forms.
24. The patient developed a fever shortly after beginning treatment with abacavir.
25. Abacavir may cause gastrointestinal side effects such as nausea and diarrhea.
26. The patient was advised not to abruptly stop taking abacavir.
27. Abacavir may cause anemia in certain patient populations.
28. The effectiveness of abacavir in pediatric patients has not been established.
29. The patient's abacavir treatment was discontinued due to a drug interaction with another medication.
30. Abacavir is contraindicated in patients with a known hypersensitivity to the drug.
Abacavir is an antiretroviral drug used to treat HIV infection; Abacavir is generally well-tolerated and effective; Abacavir should only be used in combination with other antiretroviral drugs; Regular monitoring of liver function is recommended during abacavir treatment; Abacavir hypersensitivity reactions can be life-threatening and require immediate medical attention; Abacavir may cause an increase in fatty tissue in the body, particularly in the abdomen; Abacavir should not be used in patients with HLA-B*5701 genetic markers.